200 related articles for article (PubMed ID: 31870403)
41. Improvement in clinical step and shoot intensity modulated radiation therapy delivery accuracy on an integrated linear accelerator control system.
Agnew CE; Irvine DM; Hounsell AR; McGarry CK
Pract Radiat Oncol; 2014; 4(1):43-9. PubMed ID: 24621422
[TBL] [Abstract][Full Text] [Related]
42. Improving treatment efficiency via photon optimizer (PO) MLC algorithm for synchronous single-isocenter/multiple-lesions VMAT lung SBRT.
Sanford L; Pokhrel D
J Appl Clin Med Phys; 2019 Oct; 20(10):201-207. PubMed ID: 31538721
[TBL] [Abstract][Full Text] [Related]
43. Volumetric-modulated arc therapy using multicriteria optimization for body and extremity sarcoma.
Young MR; Craft DL; Colbert CM; Remillard K; Vanbenthuysen L; Wang Y
J Appl Clin Med Phys; 2016 Nov; 17(6):283-291. PubMed ID: 27929501
[TBL] [Abstract][Full Text] [Related]
44. RapidArc patient specific mechanical delivery accuracy under extreme mechanical limits using linac log files.
Wijesooriya K; Aliotta E; Benedict S; Read P; Rich T; Larner J
Med Phys; 2012 Apr; 39(4):1846-53. PubMed ID: 22482606
[TBL] [Abstract][Full Text] [Related]
45. A comprehensive formulation for volumetric modulated arc therapy planning.
Nguyen D; Lyu Q; Ruan D; O'Connor D; Low DA; Sheng K
Med Phys; 2016 Jul; 43(7):4263. PubMed ID: 27370141
[TBL] [Abstract][Full Text] [Related]
46. Sensitivity study of an automated system for daily patient QA using EPID exit dose images.
Zhuang AH; Olch AJ
J Appl Clin Med Phys; 2018 May; 19(3):114-124. PubMed ID: 29508529
[TBL] [Abstract][Full Text] [Related]
47. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
Taggar AS; Graham D; Kurien E; Gräfe JL
J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585
[TBL] [Abstract][Full Text] [Related]
48. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
49. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
50. Rounded leaf end modeling in Pinnacle VMAT treatment planning for fixed jaw linacs.
Young LA; Yang F; Cao N; Meyer J
J Appl Clin Med Phys; 2016 Nov; 17(6):149-162. PubMed ID: 27929490
[TBL] [Abstract][Full Text] [Related]
51. Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.
Sasaki M; Nakamura M; Mukumoto N; Goto Y; Ishihara Y; Nakata M; Sugimoto N; Mizowaki T
J Appl Clin Med Phys; 2019 Oct; 20(10):118-126. PubMed ID: 31539194
[TBL] [Abstract][Full Text] [Related]
52. 4D VMAT planning and verification technique for dynamic tracking using a direct aperture deformation (DAD) method.
Zhang Y; Yang Y; Fu W; Li X; Li T; Heron DE; Huq MS
J Appl Clin Med Phys; 2017 Mar; 18(2):50-61. PubMed ID: 28300367
[TBL] [Abstract][Full Text] [Related]
53. A tool for patient-specific prediction of delivery discrepancies in machine parameters using trajectory log files.
Chuang KC; Giles W; Adamson J
Med Phys; 2021 Mar; 48(3):978-990. PubMed ID: 33332618
[TBL] [Abstract][Full Text] [Related]
54.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
55. Determination of MLC model parameters for Monaco using commercial diode arrays.
Kinsella P; Shields L; McCavana P; McClean B; Langan B
J Appl Clin Med Phys; 2016 Jul; 17(4):37-47. PubMed ID: 27455495
[TBL] [Abstract][Full Text] [Related]
56. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
Li G; Wu K; Peng G; Zhang Y; Bai S
Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
[TBL] [Abstract][Full Text] [Related]
57. DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB; AlShehri S; Alhadab A; Alqathami M
J Appl Clin Med Phys; 2019 Nov; 20(11):80-87. PubMed ID: 31605456
[TBL] [Abstract][Full Text] [Related]
58. Assessing dose rate distributions in VMAT plans.
Mackeprang PH; Volken W; Terribilini D; Frauchiger D; Zaugg K; Aebersold DM; Fix MK; Manser P
Phys Med Biol; 2016 Apr; 61(8):3208-21. PubMed ID: 27025897
[TBL] [Abstract][Full Text] [Related]
59. Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.
Huang Y; Pi Y; Ma K; Miao X; Fu S; Zhu Z; Cheng Y; Zhang Z; Chen H; Wang H; Gu H; Shao Y; Duan Y; Feng A; Zhuo W; Xu Z
Technol Cancer Res Treat; 2022; 21():15330338221104881. PubMed ID: 35726209
[No Abstract] [Full Text] [Related]
60. A novel method for routine quality assurance of volumetric-modulated arc therapy.
Wang Q; Dai J; Zhang K
Med Phys; 2013 Oct; 40(10):101712. PubMed ID: 24089902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
